Article
The DNA/RNA helicase DHX9 contributes to the transcriptional program of the androgen receptor in prostate cancer
19 May 2022
Abstract excerpt
BACKGROUND: Prostate cancer (PC) is the most commonly diagnosed male malignancy and an important cause of mortality. Androgen deprivation therapy is the first line treatment but, unfortunately, a large part of patients evolves to a castration-resistant stage, for which no effective cure is currently available. The DNA/RNA helicase DHX9 is emerging as an important regulator of cellular processes that are often...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
